1,123,810 Shares ImmuCell Corporation Common Stock, par value $0.10 per share PURCHASE AGREEMENTPurchase Agreement • January 29th, 2016 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances • New York
ImmuCell Corporation, a Delaware corporation (the “Company”), proposes to sell to Craig-Hallum Capital Group LLC (“you” or the “Underwriter”) an aggregate of 1,123,810 shares (the “Shares”) of Common Stock, par value $0.10 per share (the “Common Stock”), of the Company. The Shares consist of authorized but unissued shares of Common Stock to be issued and sold by the Company. The Shares purchased pursuant to this Purchase Agreement are herein called the “Securities.”
